Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.
G B Pier, S E Bennett
G B Pier, S E Bennett
Published February 1, 1986
Citation Information: J Clin Invest. 1986;77(2):491-495. https://doi.org/10.1172/JCI112328.
View: Text | PDF
Research Article

Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.

  • Text
  • PDF
Abstract

We analyzed high molecular weight polysaccharide (PS) from the Fisher immunotype 2 (IT-2) strain of Pseudomonas aeruginosa for molecular composition and structure, then determined its immunogenicity in healthy adults. The PS was composed of 2-acetamido-2,6-dideoxygalactose (N-acetyl fucosamine) and glucose in a molar ratio of 2:1. Structural analysis by carbon-13 and proton nuclear magnetic resonance confirmed that the high molecular weight PS was structurally identical to that of the O-specific side chain of the lipopolysaccharide. PS differed from this material in molecular size. Immunization of 19 adult volunteers with doses of 50-100 micrograms of PS resulted in significant rises (P less than 0.04-P less than 0.0001) in binding antibody levels and killing antibody titers 2 and 4 wk postimmunization. The only reaction to the vaccine was localized tenderness at the immunization site. Analysis of the immunoglobulin isotype response to the vaccine showed a rise in specific serum IgG and IgA antibodies. Heterologous responses to other P. aeruginosa PS antigens were not seen. The antibody levels attained by vaccination were comparable with those in acute-phase serum samples of patients who survived sepsis with IT-2 P. aeruginosa and were significantly higher (P less than 0.03) than specific antibody levels in bacteremic patients who died. These results confirm that PS is a high molecular weight, immunogenic form of the P. aeruginosa IT-2 serotype antigen, eliciting levels of type-specific antibody comparable with those seen among patients surviving an episode of P. aeruginosa sepsis.

Authors

G B Pier, S E Bennett

×

Total citations by year

Year: 2014 2007 2005 2003 2000 1998 1997 1996 1994 1993 1991 1990 1989 1987 Total
Citations: 1 1 1 1 1 1 1 2 3 4 1 3 2 2 24
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (24)

Title and authors Publication Year
Pseudomonas
JL Ramos, JB Goldberg, A Filloux
2014
Novel conjugate vaccine for the prevention ofPseudomonas aeruginosa infection in cystic fibrosis patients
KL Matson, JP Bratberg
Drug Development Research 2007
Pseudomonas aeruginosa: the potential to immunise against infection
E Sedlak-Weinstein, AW Cripps, JM Kyd, AR Foxwell
Expert Opinion on Biological Therapy 2005
Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen
GB Pier
Carbohydrate Research 2003
Ullmann's Encyclopedia of Industrial Chemistry
J Sandow, E Scheiffele, M Haring, G Neef, K Prezewowsky, U Stache
Ullmann's Encyclopedia of Industrial Chemistry 2000
Complex Serology and Immune Response of Mice to Variant High-Molecular-Weight O Polysaccharides Isolated fromPseudomonas aeruginosa Serogroup O2 Strains
K Hatano, GB Pier
Infection and immunity 1998
Pseudomonas aeruginosa antigens as potential vaccines
ES Stanislavsky, JS Lam
FEMS Microbiology Reviews 1997
Pseudomonas aeruginosa lipopolysaccharides and pathogenesis
JB Goldberg, GB Pier
Trends in Microbiology 1996
Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: Experimental studies in animals
HK Johansen
APMIS 1996
Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06
GB Pier, NL Koles, G Meluleni, K Hatano, M Pollack
Infection and immunity 1994
Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection
HK Johansen, F Espersen, SJ Cryz, HP Hougen, A Fomsgaard, J Rygaard, N Høiby
Infection and immunity 1994
Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa
K Hatano, S Boisot, D DesJardins, DC Wright, J Brisker, GB Pier
Infection and immunity 1994
Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody
JF Pittet, MA Matthay, G Pier, M Grady, JP Wiener-Kronish
Journal of Clinical Investigation 1993
Occurrence of a 29 kDa polysaccharide in the slime layer of both smooth and rough strains of Pseudomonas aeruginosa
M Christofidou, NK Karamanos, AC Mintzas, G Dimitracopoulos, ED Anastassiou
International Journal of Biochemistry 1993
Release of Interleukin-8, Interleukin-6, and Colony-stimulating Factors by Upper Airway Epithelial Cells: Implications for Cystic Fibrosis
M Bédard, CD McClure, NL Schiller, C Francoeur, A Cantin, M Denis
American journal of respiratory cell and molecular biology 1993
Pseudomonas aeruginosa as an Opportunistic Pathogen
M Campa, M Bendinelli, H Friedman
1993
Type-specific carbohydrate antigens of pathogenic bacteria. Part 2
AJ Griffiths, DB Davies
Carbohydrate Polymers 1991
Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients
MM Jones, DK Seilheimer, GB Pier, RD Rossen
Clinical & Experimental Immunology 1990
Polysaccharide Antigens of Pseudomonas Aeruginosa
YA Knirel
Critical Reviews in Microbiology 1990
Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients.
Jones MM, Seilheimer DK, Pier GB, Rossen RD
Clinical & Experimental Immunology 1990
In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide
GB Pier, D Thomas, G Small, A Siadak, H Zweerink
Infection and immunity 1989
Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide
GB Pier, M Pollack
Infection and immunity 1989
Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans
SJ Cryz, E Fürer, AS Cross, A Wegmann, R Germanier, JC Sadoff
Journal of Clinical Investigation 1987
Prospects for the prevention and control of Gram-negative nosocomial infections
SJ Cryz
Vaccine 1987

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts